Subscribe to our Newsletters !!


    Asthma doesn’t seem to expand the danger of contracting COVID-19, shows study

    Asthma doesn’t seem to increase the risk for an individual contracting COVID-19 or influence its own seriousness, as shown by a group of Rutgers research workers. “However, individuals with allergies –even those with diminished lung function that are being treated to control asthmatic inflammation–appear like no worse influenced by SARS-CoV-2 compared to the usual non-asthmatic

    Scientists study misleading impact in nausea therapy at the molecular level

    The molecular bases of the placebo effect are poorly understood. A team headed by Ludwig-Maximilians-Universitaet (LMU) in Munich researcher Karin Meissner has now studied the phenomenon in the context of nausea, and identified specific proteins that correlate with its positive impact. The placebo effect seems to work wonders. In certain cases, administration of a’drug’ to

    UMass Amherst scientist focuses around understanding essential parts of the hand’s microbiome

    Skin Care microbiome researcher Dr. Kelly Haas, of the University of Massachusetts Amherst’s Biology Department, recently started a research partnership with Akron, Ohio-based GOJO Industries to study the structure, stability, and endurance of their hand microbiome. The collaboration focuses on understanding fundamental aspects of the hand’s microbiome: what microbes should be growing on a hand

    Novel platform has potential to detect many disease-related biomarkers in just one test

    Most conventional molecular diagnostics usually detect only one disease-related biomarker. Fantastic examples are the PCR tests now used to diagnose COVID-19 by detecting a particular sequence from SARS-CoV-2. Such so-called singleplex methods give reliable results because they are”calibrated” to a single biomarker. However, determining whether a patient is infected with a new SARS-CoV-2 version or